Two Sigma Investments
ALNA

Two Sigma Investments’s Allena Pharmaceuticals ALNA Stock Holding History

Two Sigma Investments’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40,200
Closed -$56K – 4748
2021
Q1 		$56K Buy
+40,200
New +$67K ﹤0.01% 3738
2018
Q4 		– Sell
-15,080
Closed -$162K – 3675
2018
Q3 		$162K Sell
15,080
-13,201
-47% -$145K ﹤0.01% 3041
2018
Q2 		$369K Buy
+28,281
New +$408K ﹤0.01% 2816

Other funds holding ALNA

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Two Sigma Investments's ALNA Position: Q2 2021 in Review

Two Sigma Investments sold out of Allena Pharmaceuticals (ALNA) in Q2 2021, closing a stake of 40,200 shares — an estimated $56K sold.

Two Sigma Investments first reported a position in ALNA in Q2 2018 and held it in 3 quarters. The position peaked at $369K in Q2 2018. 29 funds tracked by Wall St. Rank hold ALNA as of Q2 2021.

  • Two Sigma Investments reported no remaining Allena Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Two Sigma Investments sold 40,200 Allena Pharmaceuticals shares in Q2 2021, an estimated $56K.
  • Two Sigma Investments first reported a position in Allena Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Two Sigma Investments's Allena Pharmaceuticals position peaked at $369K in Q2 2018.
  • 29 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2021.

Based on Two Sigma Investments's 13F filing for Q2 2021, filed 16 Aug 2021.